Zydus Cadila gets tentative USFDA nod to market anti-cancer drug
Business | September 24, 2020 11:02 ISTZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.